Table 3.
CD8 Density | Overall Survival
|
Disease-specific Survival
|
||
---|---|---|---|---|
OR (95% CI) | P Value | OR (95% CI) | P Value | |
Unadjusted | 0.12 (0.02–0.68) | .02 | 0.14 (0.03–0.78) | .02 |
Adjusted for demographic parameters* | 0.1 (0.02–0.69) | .02 | 0.06 (0.01–0.53) | .01 |
Adjusted for pathologic parameters† | 0.1 (0.01–0.69) | .02 | 0.05 (0.01–0.62) | .02 |
Adjusted for neoadjuvant therapy‡ | 0.04 (0.004–0.46) | .01 | 0.1 (0.02–0.6) | .01 |
Adjusted for intravesical therapy | 0.09 (0.01–0.58) | .01 | 0.11 (0.02–0.7) | .02 |
CI, confidence interval; OR, odds ratio.
Age and gender.
pT category, lymph node metastasis and lymphovascular invasion.
Neoadjuvant chemotherapy and neoadjuvant radiotherapy.